跳到正文

NCBI GEO 每日新增的 Series 全量同步在这里,单独归档,不混入精选信息流;少量有计算角度的数据集会进入 GEO 主题精选。

数据集

500

最新 10月31日

样本

22,480

按数据集标注累加

物种

40

按 GEO 标注去重

主题

6

共 7 类可筛选

数据概览

点击任意条目即可筛选;再次点击取消

主题由标题与摘要自动归类;样本量为数据集标注之和,SuperSeries 可能与其 SubSeries 重复计算。

全部数据集

筛选后 2 条 · 每页 30 条

清除
  • iPSC-derived antigen-presenting cells engineered to express IL12 stimulate tumor-tissue reprogramming and antitumor immunity
    GSE303722Homo sapiens; Mus musculus64 个样本2026-10-30

    Activation of cancer-reactive T cells by dendritic cells (DCs) is important for cancer elimination by host immunity. One type of cancer immunotherapy in which DCs loaded with "cancer antigens" are administered has not been able to achieve stable efficacy due to heterogeneity in cell quality dependent on patient DC status. We constructed IL12-producing antigen-presenting cells from mouse induced pluripotent stem cells (iPSC). These cells can be controlled to proliferate using cytokines, allowing for the mass production of cells with stable performance. When these cells were loaded with a model cancer antigen and administered to cancer-bearing mice, cancer-reactive T cells rapidly acquired effector functions and propagated an interferon (IFN)-stimulated gene signature to cancer tissue distant from the site of administration. This was accompanied by infiltration of effector cells into the cancer tissue, while associated with a decrease in myeloid-derived suppressor cells. These were extremely more potent than immune checkpoint inhibitors (ICIs) and were further amplified in combination with ICIs and correlated with antitumor effects. Based on these observations, we constructed IL12-producing antigen-presenting cells from human iPSCs that express only HLA molecules involved in cancer antigen presentation and exclude other HLA molecules for improved versatility. These human cells, like their mouse counterparts, were capable of cytokine-regulated proliferation and induced antigen-specific activation and IFN-γ production of cancer antigen-specific T cells. Thus, these cells may become an alternative antigen-presenting cell platform for patient DCs to overcome HLA polymorphisms and ensure stable supply and quality.

  • SCAF1 driven polyadenylation site usage regulates mRNA isoform expression and neuronal differentiation
    GSE307416Homo sapiens; Mus musculus117 个样本2026-10-26

    This SuperSeries is composed of the SubSeries listed below.

    SuperSeries